CSI Market
Sign In | Register

Crispr Therapeutics Ag (CRSP) Annual Balance Sheets

Annual · GAAP · USD millions
Access CRSP quarterly Balance Sheets →
Balance sheet patterns shown here provide context for understanding Crispr Therapeutics Ag's financial stability and long-term positioning.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent347.56
Marketable Securities, Current SH1,628.27
Cash & Short-term Investments1,975.00
Accounts receivable0.00
Prepaid Expense And Other Assets Current9.84
Total Current Assets1,985.67
Equipment/Property/Plant Net115.85
Intangible Assets0.00
Long-term investments0.00
Other Assets, Noncurrent163.72
Restricted Cash Noncurrent7.63
Operating Lease Right Of Use Asset131.72
Total Assets2,265.24
Liabilities
Accounts Payable, Current AC11.14
Accrued Liabilities, Current AC89.41
Other Liabilities, Current47.46
Taxes Payable, Current, Total1.11
Total Current Liabilities149.12
Total Long-term Debt0.00
Other liabilities, Noncurrent6.14
Contract With Customer Liability Current18.58
Contract With Customer Liability Noncurrent-
Operating Lease Liability Noncurrent188.17
Total Liabilities343.43
Stockholders' Equity
Common Stock Value3.09
Treasury Stock Value-0.06
Additional Paid In Capital Common Stock3,861.52
Retained Earnings / Accumulated Deficit-1,947.55
Other Equity4.82
Common Stockholder's Equity1,921.81
Total Stockholder's Equity1,921.81
Liabilities & Stockholder's Equity2,265.24
4 historic quarters locked

Sign in to unlock the full Crispr Therapeutics Ag balance sheet history.

Sign In Create Free Account

About Crispr Therapeutics Ag Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 12, 2026
  • Source: crsp-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-048957

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License